Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Zezina

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transplantation Proceedings|December 1, 1994
Dislipidemia at different immunosuppressive protocolsL Zezina, R Rosental
Transplantation Proceedings|May 30, 2001
Apoptosis: friend or foe?B Fellström, L Zezina
Transplantation Proceedings|March 27, 2001
Pathophysiology of the progression of renal graft dysfunctionB Fellström, E Larsson, L Zezina
Transplantation Proceedings|October 1, 1994
Alpha/beta, gamma/delta T cells and interleukin-2 receptor chain expression in kidney graft recipients under triple-drug immunosuppressionL Zezina, I Kirman, R Rosental
Transplant Immunology|April 24, 2001
Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in ratL Zezina, E Larsson, B Fellström
Transplantation Proceedings|June 18, 1999
Are there markers to initiate treatment of chronic rejection?B Fellström, U Backman, E Larsson, et al.
Transplantation Proceedings|March 20, 1999
Immunologic and nonimmunologic risk factors of chronic rejectionB Fellström, U Backman, E Larsson, et al.
Transplantation Proceedings|December 1, 1995
A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patientsR Rosental, J Bicans, R Berzina, et al.
Clinical Transplantation|January 5, 2000
Carvedilol treatment of kidney graft recipients with chronic rejectionL Zezina, B Vessby, E Larsson, et al.
Clinical Transplantation|December 31, 1997
Elevation of cyclosporin A blood levels during carvedilol treatment in renal transplant patientsM Kaijser, C Johnsson, L Zezina, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transplantation Proceedings|December 1, 1994
Dislipidemia at different immunosuppressive protocolsL Zezina, R Rosental
Transplantation Proceedings|May 30, 2001
Apoptosis: friend or foe?B Fellström, L Zezina
Transplantation Proceedings|March 27, 2001
Pathophysiology of the progression of renal graft dysfunctionB Fellström, E Larsson, L Zezina
Transplantation Proceedings|October 1, 1994
Alpha/beta, gamma/delta T cells and interleukin-2 receptor chain expression in kidney graft recipients under triple-drug immunosuppressionL Zezina, I Kirman, R Rosental
Transplant Immunology|April 24, 2001
Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in ratL Zezina, E Larsson, B Fellström
Transplantation Proceedings|June 18, 1999
Are there markers to initiate treatment of chronic rejection?B Fellström, U Backman, E Larsson, et al.
Transplantation Proceedings|March 20, 1999
Immunologic and nonimmunologic risk factors of chronic rejectionB Fellström, U Backman, E Larsson, et al.
Transplantation Proceedings|December 1, 1995
A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patientsR Rosental, J Bicans, R Berzina, et al.
Clinical Transplantation|January 5, 2000
Carvedilol treatment of kidney graft recipients with chronic rejectionL Zezina, B Vessby, E Larsson, et al.
Clinical Transplantation|December 31, 1997
Elevation of cyclosporin A blood levels during carvedilol treatment in renal transplant patientsM Kaijser, C Johnsson, L Zezina, et al.
Pageof 2